inogatran has been researched along with Recrudescence in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersen, K; Dellborg, M; Emanuelsson, H; Grip, L; Swedberg, K | 1 |
Andersen, K; Dellborg, M | 1 |
Abrahamsson, P; Andersen, K; Clemmensen, P; Dellborg, M; Grande, P; Holmvang, L; Wagner, G | 1 |
3 trial(s) available for inogatran and Recrudescence
Article | Year |
---|---|
Thrombin inhibition with inogatran for unstable angina pectoris: evidence for reactivated ischaemia after cessation of short-term treatment.
Topics: Adult; Aged; Angina, Unstable; Antithrombins; Drug Tolerance; Female; Follow-Up Studies; Glycine; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Piperidines; Recurrence; Thrombin; Vectorcardiography | 1996 |
Heparin is more effective than inogatran, a low-molecular weight thrombin inhibitor in suppressing ischemia and recurrent angina in unstable coronary disease. Thrombin Inhibition in Myocardial Ischemia (TRIM) Study Group.
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Anticoagulants; Antithrombins; Double-Blind Method; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Glycine; Heparin; Humans; Male; Middle Aged; Myocardial Ischemia; Piperidines; Prospective Studies; Recurrence; Thrombin; Vectorcardiography | 1998 |
Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease.
Topics: Aged; Angina Pectoris; Angina, Unstable; Anticoagulants; Antithrombins; Coronary Disease; Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Glycine; Heparin; Humans; Hypertension; Male; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Patient Admission; Piperidines; Prognosis; Recurrence; Risk Assessment; Risk Factors; Survival Rate; Vectorcardiography | 1999 |